Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
TAC regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. :
Access to resources
Recommend
Trastuzumab improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
Adjuvant regimen with docetaxel best bet in operable breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
Adjuvant regimen with docetaxel best bet in operable breast cancer
Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. :
Docetaxel delivers over doxorubicin for early breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :